Clinic News Latest in CardiologyREVIVED and STICH: Revascularization Versus Guideline Directed Medical Therapy in Ischemic Left Ventricular Systolic DysfunctionCoronary artery disease (CAD) continues to be the leading cause of heart failure (HF) globally. The concept of salvaging hibernating myocardium in order to improve morbidity and mortality in patients with HF has been a topic of discussion for many years.Health Care Policy and CHD – 2020 Focus on Our 2030 Future: Top 10 Things to KnowCongenital heart disease (CHD) is the most common birth defect and the leading cause of morbidity and mortality in children.ACCEL Lite: Improving characterization of Stage A and B HF by adding StrainIn this interview, Professor Tom Marwick MBBS, PhD, MPH, FAHMS and John Gorcsan III MD, FACC discuss improving characterization of Stage A and B HF by adding strain.2-Year Outcomes of Transcatheter MV Replacement for MV DiseaseWhat are the 2-year outcomes of valve-in-mitral annular calcification (ViMAC), mitral valve-in-ring (MViR), and valve-in-valve (MViV) in the MITRAL (Mitral Implantation of Transcatheter Valves) trial?Prediction of Survival After Fully Magnetically Levitated LVADFor patients with a HeartMate 3 (HM3) left ventricular assist device (LVAD), can a pre-implant risk score be developed and validated to predict 1- and 2-year survival after LVAD implant?Cutting Back on Using the Salt Shaker Reduces CVD RiskReducing sodium intake by less frequently adding salt to food after it is cooked is associated with a reduced risk of ischemic heart disease (IHD), heart failure (HF) and stroke, according to a study published Nov. 28 in JACC.Statin-Associated Muscle Symptoms and Vitamin D SupplementationDoes vitamin D supplementation prevent statin-associated muscle symptoms (SAMS)? Renal Denervation in the Treatment of Resistant HypertensionHypertension (HTN) affects approximately 50% of the adult population and is one of the most important contributors to cardiovascular morbidity and mortality.Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of Nov. 21)In this week’s View, Dr. Eagle discusses trends in the use of oral anticoagulants in older adults with newly diagnosed atrial fibrillation, then looks at a collaborative meta-analysis of large placebo-controlled trials that examines the impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes.Practical Approach to Left Main Coronary Artery Disease: Key PointsThe following are key points to remember from this state-of-the-art review on a practical approach to left main (LM) coronary artery disease (CAD).
